Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2006 | |
| Sales | 57,820 | 0 | 0 |
| Cost of Goods | 25,350 | N/A | N/A |
| Gross Profit | 32,470 | N/A | N/A |
| Operating Expenses | 11,780 | 0 | 0 |
| Operating Income | 21,040 | N/A | N/A |
| Interest Expense | 2,150 | 0 | 0 |
| Other Income | -2,090 | 0 | 0 |
| Pre-tax Income | 16,800 | 0 | 0 |
| Income Tax | 360 | N/A | N/A |
| Net Income Continuous | 16,432 | 12,791 | N/A |
| Net Income | $16,430 | $12,791 | $N/A |
| EPS Basic Total Ops | 0.74 | 0.60 | N/A |
| EPS Basic Continuous Ops | 0.74 | 0.60 | N/A |
| EPS Diluted Total Ops | 0.66 | 0.54 | N/A |
| EPS Diluted Continuous Ops | 0.66 | 0.53 | N/A |
| EBITDA(a) | $24,640 | $N/A | $N/A |